Colgate Secures Rx-To-OTC Switch Of Duraphat In Norway
Colgate's high-fluoride toothpaste Duraphat will soon be available OTC in Norway after the country switched the product into its new "non-prescription medicines with guidance" category.
You may also be interested in...
Pfizer has taken the first steps towards turning its Viagra erectile dysfunction treatment into a pan-European OTC brand by taking advantage of Norway's new "non-prescription medicines with guidance" category to secure the Rx-to-OTC switch of the product. Norway will be the second European market where Viagra is available OTC after the UK switched the drug in 2017.
A round-up of the latest European executive appointments: CRN UK hires scientific advisor; EMA management board names vice chair; Boots UK appoints chief digital officer.
French natural consumer health specialist Havea looks set to be snapped up by private-equity firm BC Partners, which has set out a plan to step up the company's M&A and digitization activities.